APA (7th ed.) Citation

Vučković, J., Pajič, T., Kušec, R., Grat, M., Lorbek, M., Rogulj, D., . . . Žuran, I. (2006, October). Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience. Zdravniški Vestnik.

Chicago Style (17th ed.) Citation

Vučković, Joško, Tadej Pajič, Rajko Kušec, Mateja Grat, Marjan Lorbek, Dinko Rogulj, Rok Pavlič, and Ivan Žuran. "Clinical Meaning of JAK2 V617F Mutation in Chronic Myeloproliferative Disorders – the First Experience." Zdravniški Vestnik Oct. 2006.

MLA (9th ed.) Citation

Vučković, Joško, et al. "Clinical Meaning of JAK2 V617F Mutation in Chronic Myeloproliferative Disorders – the First Experience." Zdravniški Vestnik, Oct. 2006.